Cash Burn of $4.0 million in Q1 remains in line with projected quarterly range Cash and investments on hand are sufficient to fund operations beyond the anticipated FDA decision of VenoValve and the initiation of the enVVe pivotal trial FDA decision on PMA application for the VenoValve expected in the second half of 2025 On track for enVVe IDE application submission in Q3 of 2025, pending GLP study results IRVINE, CA / ACCESS Newswire / May 1, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous …

Suspicions about stock market foul play have been rampant in recent weeks due to multiple strange moves observable in the intraday performance of benchmark indices such as the S&P 500.

Roblox raised its annual bookings forecast on Thursday and beat quarterly results estimates, a sign that spending on its vast library of user-generated videogames was holding up despite economic uncertainty driven by U.S. tariffs.

AVENTURA, Fla.--(BUSINESS WIRE)--Safe Pro Group Inc. (Nasdaq: SPAI) (“Safe Pro” or the “Company”), a leading provider of artificial intelligence (AI)-driven security solutions, today announced it has successfully completed multiple demonstrations of its patented Safe Pro Object Threat Detection (SPOTD) technology to various branches of the U.S. Department of Defense. Following these briefings, the Company commenced the integration of its SPOTD technology onto the Win-TAK platform, part of the U.

McDonald's posted mixed Q1 results Thursday with declines in revenue and comparable sales. McDonald's stock slides.

According to many economists, low to middle-income consumers are strapped and taking a break from spending as they reduce the debt they accumulated on credit cards. Another group of consumers continues to spend but does so selectively.

Technology stocks are anticipated to lead a Wall Street rally to start the month of May on Thursday, following earnings from Microsoft and Meta Platforms overnight and ahead of more from Apple and Amazon after the close. Futures markets are calling the Nasdaq 100 around 1.7% higher, ahead of the opening bell, with S&P 500 futures up 1.2% and those for the Dow Jones rising 0.8%.

ATLANTA, May 01, 2025 (GLOBE NEWSWIRE) -- Cumulus Media Inc. (NASDAQ: CMLS) (the "Company," "Cumulus Media," "we," "us," or "our") today announced operating results for the three months ended March 31, 2025.

PURCHASE, N.Y.--(BUSINESS WIRE)--Mastercard announced its first quarter 2025 financial results through an earnings release available on the company's Investor Relations website.

BRIDGEWATER, NJ / ACCESS Newswire / May 1, 2025 / Tharimmune, Inc., (Nasdaq:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology announced abstracts featuring clinical data on its lead drug candidate, TH104, have been accepted for presentation at the Digestive Disease Week (DDW) Annual Meeting and at the European Association for the Study of the Liver (EASL) International Liver Congress. Both conferences will take place in May 2025.

The tariff-driven market volatility has been rough on shares of Chinese EV maker Nio Inc.

Alliant Energy has a long track record of dividend increases, offering defensive growth in a volatile market.

London-based Marex stock hit new highs after breaking out past a buy point. Will the company's first-quarter results impress Wall Street?

I rate RELX as a Buy following my assessment of its first quarter commentary and FY2025 outlook. The company's STM segment shouldn't be substantially affected by reductions in US research funding. RLXXF's top-line mix is favorable, and its group-level financial performance is expected to be fairly resilient even if the American economy's growth slows.

BOCA RATON, May 01, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: JNVR) (“DeFi Dev Corp” or the “Company”) today announces that it has entered into a securities purchase agreement for a private investment in public equity (“PIPE”) financing that is expected to result in gross proceeds of approximately $24 million to the Company, before placement agent fees and offering expenses. Investors include Galaxy Digital, Amber International Holding Limited (Nasdaq: AMBR), Arrington Capital, Republic Digital, Borderless Capital, RK Capital, and Great Point Capital.

Brera's Strategy of Sustainable Growth and Local Engagement Reflects Evolving Industry Best Practices, Including Bottom-Up Value Creation Brera's Strategy of Sustainable Growth and Local Engagement Reflects Evolving Industry Best Practices, Including Bottom-Up Value Creation

Phase 2 biomarker trial in FECD patients anticipated to begin in the second half of 2025 Phase 2 biomarker trial in FECD patients anticipated to begin in the second half of 2025

REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism, today announced that management will participate in the following investor conferences:

SILVER SPRING, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its first quarter 2025 financial results after market close on Thursday, May 8, 2025. Members of the Company's management team will host a conference call and webcast starting at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time on the same day.

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that the Company will present 36-week data from the ASPIRE Phase 2B study at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting being held on May 4-8, 2025 in Salt Lake City, Utah.